Anugerah 88 Logo
$33.28-0.64|(-1.89%)
52W H: 49.911452W L: 14.72Beta: 1.53

About First Tracks Biotherapeutics Inc

Frequently Asked Questions

What is the 52-week range for TRAX?

The 52-week high is $49.9114 and the 52-week low is $14.72.

What is the P/E ratio for TRAX?

The P/E ratio data is currently unavailable.

What is the dividend yield for TRAX?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

ROE data is currently unavailable.

What is the Net Profit Margin?

Net Margin data is currently unavailable.

What is the Price to Book (P/B) Ratio?

P/B ratio data is currently unavailable.

Analyst Recommendation Trends

Wall Street analyst consensus for TRAX over the last few months:

2026-09-01
Buy: 9
S.Buy: 5
Hold: 1
Sell: 0
2026-08-01
Buy: 9
S.Buy: 4
Hold: 1
Sell: 0
2026-07-01
Buy: 9
S.Buy: 4
Hold: 1
Sell: 0
2026-06-01
Buy: 7
S.Buy: 4
Hold: 1
Sell: 0

Latest TRAX News

Canaccord Genuity Initiates Coverage On First Tracks with Buy Rating, Announces Price Target of $50

Canaccord Genuity analyst Edward Nash initiates coverage on First Tracks (NASDAQ:TRAX) with a Buy rating and announces Price Target of $50.

Benzinga9/30/2026

AnaptysBio (ANAB) Reports a Tax-Driven Profit. When Will Royalties Fund Shareholder Returns?

AnaptysBio, Inc. (NASDAQ:ANAB) reported $176.4 million of income from continuing operations for the six months ended June 30 in results released September 21. A $181.5 million income-tax benefit, primarily from releasing a deferred-tax valuation allowance, turned a $5.1 million pretax loss into that profit. The tax adjustment reflects greater expected use of tax assets following […]

Yahoo9/26/2026

This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Analysts initiated bullish coverage on TRAX, BGSI, NPCE, CUE and NGVC, assigning Outperform/Buy ratings with price targets from $18 to $120.

Benzinga9/18/2026

Evercore ISI Group Initiates Coverage On First Tracks with Outperform Rating, Announces Price Target of $65

Evercore ISI Group initiates coverage on First Tracks (NASDAQ:TRAX) with a Outperform rating and announces Price Target of $65.

Benzinga9/18/2026

Guggenheim Initiates Coverage On First Tracks with Buy Rating, Announces Price Target of $100

Guggenheim analyst Yatin Suneja initiates coverage on First Tracks (NASDAQ:TRAX) with a Buy rating and announces Price Target of $100.

Benzinga9/16/2026

Rosnilimab Emerges as a Potential Advance in Rheumatoid Arthritis as Physicians Look to the Next Wave of Pipeline Innovation

New Spherix Global Insights research finds rheumatologists estimate 16% of rheumatoid arthritis patients are refractory to treatment, underscoring continued demand for differentiated therapies despite an increasingly crowded market.Exton, PA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- As the Rheumatoid Arthritis (RA) treatment landscape becomes increasingly competitive, rheumatologists are looking to the pipeline for therapies that can offer more than incremental differentiation. New research from Spher

Yahoo9/10/2026

Related Stocks (Peers)

Companies operating in similar sectors to TRAX:

DMRAORICREPLMNKDTRAXBCAX2592.HKVORMGTXJANXAKTS950160.KQ

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-09-15Orwin John A-1,300--
2026-09-15Orwin John A+1,300--
2026-09-02Ware J. Anthony-10,694--
2026-09-02Ware J. Anthony-28,571--
2026-09-02Ware J. Anthony-39,265$44.7764$1,758,145
2026-09-02Ware J. Anthony+39,265$5.74$225,381
2026-08-15STONE BENJAMIN+60,492--
2026-08-15Lizzul Paul F.+60,492--
2026-08-15Faga Daniel+193,575--
2026-08-02STONE BENJAMIN+60,492--
2026-08-02Lizzul Paul F.+60,492--
2026-08-02Faga Daniel+193,576--
2026-06-15Marquet Magda-6,030--
2026-06-15Marquet Magda+6,030--
2026-06-15Schmid John P.-6,030--
2026-06-15Schmid John P.+6,030--
2026-06-15Orwin John A-6,030--
2026-06-15Orwin John A+6,030--
2026-06-15FENTON DENNIS M-6,030--
2026-06-15FENTON DENNIS M+6,030--
2026-05-12Ware J. Anthony+7,000--
2026-05-12Ware J. Anthony+2,500--
2026-05-12Jain Rita+7,000--
2026-05-12Jain Rita+2,500--
2026-05-12Marquet Magda+7,000--
2026-05-12Marquet Magda+2,500--
2026-05-12Schmid John P.+7,000--
2026-05-12Schmid John P.+2,500--
2026-05-12Orwin John A+7,000--
2026-05-12Orwin John A+2,500--
2026-05-12FENTON DENNIS M+7,000--
2026-05-12FENTON DENNIS M+2,500--
2026-05-12STONE BENJAMIN+72,300--
2026-05-12STONE BENJAMIN+26,700--
2026-05-12Tamboli Ajim+13,600--
2026-05-12Tamboli Ajim+5,000--
2026-05-12Ware J. Anthony+42,000--
2026-05-12Ware J. Anthony+15,000--
2026-05-12Lizzul Paul F.+72,300--
2026-05-12Lizzul Paul F.+26,700--
2026-05-12Jain Rita+42,000--
2026-05-12Jain Rita+15,000--
2026-05-12Faga Daniel+271,100--
2026-05-12Faga Daniel+100,200--
2026-05-12Marquet Magda+42,000--
2026-05-12Marquet Magda+15,000--
2026-05-12Schmid John P.+42,000--
2026-05-12Schmid John P.+15,000--
2026-05-12Orwin John A+42,000--
2026-05-12Orwin John A+15,000--
2026-05-12FENTON DENNIS M+42,000--
2026-05-12FENTON DENNIS M+15,000--
2026-04-23Tamboli Ajim+41,234--
2026-04-22Tamboli Ajim+41,233--
2026-04-21Tamboli Ajim+41,233--
2026-04-21Tamboli Ajim+45,700--
2026-04-20Ware J. Anthony+4,000--
2026-04-20Ware J. Anthony+6,030--
2026-04-20Ware J. Anthony+5,500--
2026-04-20Ware J. Anthony+16,510--
2026-04-20Ware J. Anthony+16,510--
2026-04-20Ware J. Anthony+10,600--
2026-04-20Ware J. Anthony+9,200--
2026-04-20Ware J. Anthony+11,000--
2026-04-20Ware J. Anthony+11,000--
2026-04-20Ware J. Anthony+6,000--
2026-04-20Ware J. Anthony+6,000--
2026-04-20Ware J. Anthony+10,694--
2026-04-20Ware J. Anthony+28,571--
2026-04-20Lizzul Paul F.+21,400--
2026-04-20Lizzul Paul F.+25,575--
2026-04-20Lizzul Paul F.+21,110--
2026-04-20Lizzul Paul F.+6,145--
2026-04-20Lizzul Paul F.+29,000--
2026-04-20Lizzul Paul F.+97,200--
2026-04-20Lizzul Paul F.+115,540--
2026-04-20Lizzul Paul F.+67,070--
2026-04-20Lizzul Paul F.+70,000--
2026-04-20Lizzul Paul F.+45,000--
2026-04-20Lizzul Paul F.+83,500--
2026-04-20Jain Rita+4,000--
2026-04-20Jain Rita+6,030--
2026-04-20Jain Rita+1,300--
2026-04-20Jain Rita+5,500--
2026-04-20Jain Rita+16,510--
2026-04-20Jain Rita+16,510--
2026-04-20Jain Rita+8,015--
2026-04-20Jain Rita+10,600--
2026-04-20Faga Daniel+98,600--
2026-04-20Faga Daniel+80,512--
2026-04-20Faga Daniel+69,355--
2026-04-20Faga Daniel+17,850--
2026-04-20Faga Daniel+133,400--
2026-04-20Faga Daniel+305,500--
2026-04-20Faga Daniel+379,620--
2026-04-20Faga Daniel+194,900--
2026-04-20Faga Daniel+9,200--
2026-04-20Faga Daniel+2,321--
2026-04-20Faga Daniel+11,000--
2026-04-20Marquet Magda+4,000--
2026-04-20Marquet Magda+6,030--
2026-04-20Marquet Magda+5,500--
2026-04-20Marquet Magda+16,510--
2026-04-20Marquet Magda+16,510--
2026-04-20Marquet Magda+10,600--
2026-04-20Marquet Magda+9,200--
2026-04-20Marquet Magda+11,000--
2026-04-20Marquet Magda+784--
2026-04-20EcoR1 Capital, LLC+4,705,575$13.8134$64,999,990
2026-04-20Schmid John P.+4,000--
2026-04-20Schmid John P.+6,030--
2026-04-20Schmid John P.+5,500--
2026-04-20Schmid John P.+16,510--
2026-04-20Schmid John P.+16,510--
2026-04-20Schmid John P.+10,600--
2026-04-20Schmid John P.+9,200--
2026-04-20Schmid John P.+11,000--
2026-04-20Schmid John P.+11,000--
2026-04-20Schmid John P.+6,000--
2026-04-20Schmid John P.+6,000--
2026-04-20Schmid John P.+15,000--
2026-04-20Orwin John A+6,000--
2026-04-20Orwin John A+6,030--
2026-04-20Orwin John A+1,300--
2026-04-20Orwin John A+8,250--
2026-04-20Orwin John A+16,510--
2026-04-20Orwin John A+16,510--
2026-04-20Orwin John A+10,600--
2026-04-20Orwin John A+3,311--
2026-04-20ANAPTYSBIO, INC-100--
2026-04-20FENTON DENNIS M+4,000--
2026-04-20FENTON DENNIS M+6,030--
2026-04-20FENTON DENNIS M+5,500--
2026-04-20FENTON DENNIS M+16,510--
2026-04-20FENTON DENNIS M+16,510--
2026-04-20FENTON DENNIS M+10,600--
2026-04-20FENTON DENNIS M+9,200--
2026-04-20FENTON DENNIS M+11,000--
2026-04-20FENTON DENNIS M+11,000--
2026-04-20FENTON DENNIS M+6,000--
2026-04-20FENTON DENNIS M+5,507--
2026-04-20FENTON DENNIS M+6,000--